Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02093988Phase 1Unknown
Phase 1, randomised, triple-blind trial of tranexamic acid in hemorrhage (2 arms), sponsored by University of British Columbia. Primary endpoint: Volume of Blood Loss. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02093988.